wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38832902-8A28AAD6-55A1-4132-9780-D7569DBC5238
Q38832902-8A28AAD6-55A1-4132-9780-D7569DBC5238
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38832902-8A28AAD6-55A1-4132-9780-D7569DBC5238
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
P2860
Q38832902-8A28AAD6-55A1-4132-9780-D7569DBC5238
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38832902-8A28AAD6-55A1-4132-9780-D7569DBC5238
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed9ebf5cd0d0c718aa9ce7b22f6a6ca480f724fa
P2860
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada